After a sell-off, this medical device stock looks like a gift for patient investors
0 14 mins 2 mths

After a sell-off, this medical device stock looks like a gift for patient investors

Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes represents a major untapped market for the company and GLP-1 adoption potentially will expand rather than cannibalize the opportunity for Insulet’s Omnipod insulin delivery system. The stock’s […]

Health